142 related articles for article (PubMed ID: 21928424)
1. Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis.
Kline ER; Muller S; Pan L; Tighiouart M; Chen ZG; Marcus AI
Head Neck; 2011 Oct; 33(10):1501-12. PubMed ID: 21928424
[TBL] [Abstract][Full Text] [Related]
2. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
7. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
[TBL] [Abstract][Full Text] [Related]
8. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
Zhang X; Hunt JL; Shin DM; Chen ZG
Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307
[TBL] [Abstract][Full Text] [Related]
10. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
13. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma.
Ueda M; Shimada T; Goto Y; Tei K; Nakai S; Hisa Y; Kannagi R
Auris Nasus Larynx; 2010 Aug; 37(4):488-95. PubMed ID: 20036791
[TBL] [Abstract][Full Text] [Related]
14. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
15. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Wang SJ; Wreesmann VB; Bourguignon LY
Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of micrometastases detection in lymph nodes from head and neck squamous cell carcinoma.
Xu Y; Lefèvre M; Périé S; Tao L; Callard P; Bernaudin JF; St Guily JL
Otolaryngol Head Neck Surg; 2008 Sep; 139(3):436-41. PubMed ID: 18722227
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients.
Nijkamp MM; Span PN; Hoogsteen IJ; van der Kogel AJ; Kaanders JH; Bussink J
Radiother Oncol; 2011 Jun; 99(3):344-8. PubMed ID: 21684617
[TBL] [Abstract][Full Text] [Related]
18. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
[TBL] [Abstract][Full Text] [Related]
20. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck.
Rhee D; Wenig BM; Smith RV
Laryngoscope; 2002 Nov; 112(11):1970-4. PubMed ID: 12439164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]